Chronic hepatitis C therapy early on can prevent the development of hardening toward the liver (cirrhosis) and liver cancer.
"Infection with hepatitis C can be treated and most curable.
Results for 10-year study showed early treatment may prevent cirrhosis and reduce the risk of liver cancer and death.
Cost of maintenance can also be suppressed," said Chief Researcher Heart Association Indonesia (PPHI) Dr.
Superior Budihusodo, SpPD, KGEH.
According to him, therapy for hepatitis C is primarily intended to eliminate the virus, stop the progression of the disease and eliminate the symptoms of the disease include marked with distended bellies, swollen feet and yellow body.
Gold standard therapy for hepatitis C today, he says, is treatment with a combination of pegylated interferon alfa and ribavirin therapy with long depending on the HCV genotype.
"The success of therapy is influenced by the genotype of the virus, the amount of virus, patient age, disease condition, when starting therapy and patient compliance during therapy," he said.
Furthermore, he explains, chronic inflammation of the liver infection hepatitis C virus (HCV) did not show early symptoms that could be identified that approximately 90% of people who have hepatitis C do not realize he was infected.
"Around 80-90% of cases showed symptoms and signs are minimal.
New symptoms appear when complications have occurred at an advanced stage, when it is bad," he said.
The development of liver disease from HCV infection until the beginning of liver cancer, according to him, too long of between 20 years to 30 years.
Therefore, he continued, should be scanning at high-risk groups are infected with hepatitis C to find the earliest possible cases of hepatitis C infection and handle it immediately.
Government together with stakeholders to ensure the disease surveillance system effective for improving the case finding that infections spread by contact with blood or infected body fluids such as blood transfusion, unsafe sex, tattoos, body piercing and injection with the needle.
The diagnosis of hepatitis C infection, according to Superior, is based on the results of hepatitis C virus in the blood by scanning anti-HCV and HCV RNA quantitative.
(ant / cax)
"Infection with hepatitis C can be treated and most curable.
Results for 10-year study showed early treatment may prevent cirrhosis and reduce the risk of liver cancer and death.
Cost of maintenance can also be suppressed," said Chief Researcher Heart Association Indonesia (PPHI) Dr.
Superior Budihusodo, SpPD, KGEH.
According to him, therapy for hepatitis C is primarily intended to eliminate the virus, stop the progression of the disease and eliminate the symptoms of the disease include marked with distended bellies, swollen feet and yellow body.
Gold standard therapy for hepatitis C today, he says, is treatment with a combination of pegylated interferon alfa and ribavirin therapy with long depending on the HCV genotype.
"The success of therapy is influenced by the genotype of the virus, the amount of virus, patient age, disease condition, when starting therapy and patient compliance during therapy," he said.
Furthermore, he explains, chronic inflammation of the liver infection hepatitis C virus (HCV) did not show early symptoms that could be identified that approximately 90% of people who have hepatitis C do not realize he was infected.
"Around 80-90% of cases showed symptoms and signs are minimal.
New symptoms appear when complications have occurred at an advanced stage, when it is bad," he said.
The development of liver disease from HCV infection until the beginning of liver cancer, according to him, too long of between 20 years to 30 years.
Therefore, he continued, should be scanning at high-risk groups are infected with hepatitis C to find the earliest possible cases of hepatitis C infection and handle it immediately.
Government together with stakeholders to ensure the disease surveillance system effective for improving the case finding that infections spread by contact with blood or infected body fluids such as blood transfusion, unsafe sex, tattoos, body piercing and injection with the needle.
The diagnosis of hepatitis C infection, according to Superior, is based on the results of hepatitis C virus in the blood by scanning anti-HCV and HCV RNA quantitative.
(ant / cax)
SHARE
![Pediatric Supportive Care (PDQ®): Supportive care - Patient Information [NCI]-Overview](https://cdnus.oss-us-west-1.aliyuncs.com/libs/images/NewsJpg/cate_6/072_215x160.jpg)
